about
Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo.Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune responseTherapy of established B16-F10 melanoma tumors by a single vaccination of CTL/T helper peptides in VacciMaxRejection of large HPV-16 expressing tumors in aged mice by a single immunization of VacciMax encapsulated CTL/T helper peptides.Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines.A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not Treg/Tr1-type responses.Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform.Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRI.A liposome-based platform, VacciMax, and its modified water-free platform DepoVax enhance efficacy of in vivo nucleic acid delivery.Multi-modal treatment with peptide vaccine, metronomic cyclophosphamide and anti-PD1 monoclonal antibody provides effective control of tumors in multiple modelsSingle dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal spore inhalation challengeEvaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein
P50
Q33853324-360D1B34-DE34-4908-8D77-7DB51CCA72A9Q35201890-BC30EC6C-4516-48BA-B513-E4B875E1F68EQ35790603-2AF1CC6A-1A43-4904-BA71-B089BEFBD343Q35865140-42522B93-971D-4DB8-9728-C3EFFB1B2756Q38161367-900C8450-88AF-405B-B33E-2433BCA186DBQ39707203-C9E6AD21-2E83-4753-A839-B7BCD938A38CQ48316344-B5C00759-5C7A-4F1B-9062-344DEA35934FQ48695533-0DC5909E-8646-4431-89C8-363068A34CE8Q50545939-82F7625A-9EE4-4BE7-9CD5-526752A1AAF8Q59323038-AD1ADAF1-3FB3-4612-B955-ECD40BAED429Q61797561-A30D0F89-5F95-44AD-AFF8-80810153DE96Q96341204-BAD2A03F-2E07-40C6-8D94-BD4ABA3D8E4D
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-6285-7187
@en
name
Genevieve M Weir
@ast
Genevieve M Weir
@en
Genevieve M Weir
@nl
type
label
Genevieve M Weir
@ast
Genevieve M Weir
@en
Genevieve M Weir
@nl
prefLabel
Genevieve M Weir
@ast
Genevieve M Weir
@en
Genevieve M Weir
@nl
P106
P31
P496
0000-0002-6285-7187